1. Invited as a Special guest of the conference on "Prevention, Diagnosis and Treatment for Hepatitis" organised by Illness To Wellness Foundation (ITWF) on occasion of World Hepatitis Day on 28th July 2025, New Delhi. Presented in "Barriers and Solutions to Hepatitis Elimination" session, followed by panel discussion.
2. Selected as member of Implementation research (IR) teams of ICMR by Hon'ble DG, ICMR, March 2023
3. Invited as Guest speaker at National CME “Hepatitis B – Mitigation and working towards elimination” on the occasion of World Hepatitis day held at AIIMS Bibinagar, Hyderabad on 28th July 2021
4. Women Warriors of ICMR Women scientists leading India’s fight against COVID-19’: E-Samvad Patrika of ICMR, March 2021
5. Exemplary services during SARS-CoV-2 Pandemic from Director ICMR-NIV, Pune: Certificate of appreciation, 5th February 2021
6. Guest lecture: CME on COVID-19 organized by the Vidarbha Association of Medical Microbiologists (VAMM) on "Laboratory diagnosis of COVID-19 with special reference to Neuro COVID", 8th August 2020
7. Speaker on All India Radio(AIR), New Delhi broadcast on novel coronavirus(nCoV) Precautions, 26^th February 2020
8. Nominated as Member of Central Team of experts to Udhampur, Jammu & Kashmir to investigate pediatric deaths due to unknown etiology constituted by the Emergency Medical Relief (EMR), Ministry of Health and Family Welfare, Govt. of India, January 2020
9. Guest lecture in CME on “Acute Encephalitis Syndrome and Vector Borne Diseases”, organized by MGIMS, Sevagram, 1st June, 2019
10. Won First prize in Oral Presentation on “Zika virus outbreak in Jaipur, Rajasthan: Experience during response”: CME on “Outbreak Management” at KEM, Hospital organized by Hospital Infection Society –Mumbai Forum on 16th February 2019
11. Invited as Judge for Poster presentation (Medical) in the 27th International Conference Of Virology (INTERVIROCON 2018) under the aegis of Indian Virological Society (IVS), New Delhi from 12th to 14th November 2018 at PGIMER, Chandigarh
12. Nominated as High Level Central Team Member: Zika virus outbreak at Jaipur, Rajasthan, September 2018
13. Nominated as member of Central team for Nipah virus outbreak at Kozhikode, Kerala (June, 2018) by Emergency Medical Relief (EMR) Division of the Directorate General of Health Services, Govt. of India

Educational qualifications: MBBS, MD Microbiology, PGD Epidemiology

1. 13th International Conference on Health and Hepatitis in Substance Users, held from October 14-17, 2025: Presented her research work on: "Whole Genome Sequencing and Drug Resistance analysis of ‘Unusual’ Hepatitis C subtypes 6xa and a 3b relapse Case: A study on Intravenous Drug-Users On Direct-Acting Antiviral (DAA) Treatment, India
2. Hands-on Basic flow cytometry course at BD–NCBS Centre of Excellence in Flow Cytometry, 22^nd to 24^th April 2025 at NCBS-TIFR, Bengaluru
3. Implementation Research Workshop, 6^th to 8^th September 2023 at ICMR- NIIRNCD, Jodhpur
4. Training programme on “Viral Hepatitis”, 21^st – 22^nd February, 2023, Institute of Liver & Biliary Sciences (ILBS), New Delhi
5. 4-day Training Programme on ''LQMS and Internal Audit as per IS/ISO/IEC 17025:2017", 21^st to 24^th November 2022, National Institute of Training for Standardization (NITS), Bureau of Indian Standards (BIS), NOIDA
6. Workshop on Health Technology Assessment (HTA), 28^th July 2025, ICMR-NIV, Pune
7. 8th Training Programme on “Science and Technology for Rural Societies for Women Scientist & Technologists”, 25^th to 29^th November 2019, Indian Institute of Public Administration (IIPA), New Delhi, sponsored by DST
8. Training workshop on “Ethical Guidance for Biomedical Research”, 17^th – 18^th January 2019, ICMR-National AIDS Research Institute(NARI), Pune
9. Capacity building workshop on “Risk communication during Public Health Emergencies”, 14^th – 15^th May 2018, Organized by National Centre for Disease Control (NCDC), in collaboration with World Health organization (WHO), Country Office for India at Shimla
10. Training Program on “Basic Epidemiology and Biostatistics”, 9^th – 20^th April 2018, ICMR-National Institute of Epidemiology(NIE), Chennai
11. Public Health Dynamics Workshop (PHD 2018), 5^th – 7^th March 2018, ICMR headquarters, New Delhi (Public Health Dynamics Laboratory, University of Pittsburgh Graduate School of Public Health)

1. Tandale BV, Khude PM, Deshmukh PS, Qazi MS, Padmaja GV, Narang R, Deshmukh PR, Rajderkar SS, Tomar SJ, Bondre VP, et al; Japanese Encephalitis Epidemiology in Central India Study Group. Epidemiology of Japanese encephalitis in Central India after implementing immunization. J Pediatr Infect Dis. 2024. doi:10.1055/s-0044-1785490
2. Alagarasu K, Tomar SJ, Patil J, Bachal R, More R, Bote M, Kakade M, Venkatesh V, Parashar D, Tandale BV. Seroprevalence of dengue virus infection in Pune City in India, 2019: a decadal change. J Infect Public Health. 2023;16(11):1830-1836. doi:10.1016/j.jiph.2023.08.020
3. Tandale BV, Narang R, Kumar GV, Jain M, Tomar SJ, Deshmukh PS. Infectious causes of acute encephalitis syndrome in India: decadal change and the way forward. Indian Pediatr. 2023. PMID:37260063
4. Tandale BV, Deshmukh PS, Tomar SJ, Narang R, Qazi MS, Padmaja GV, Jain M, Jain D, Guduru VK, Jain J, et al. Incidence of Japanese encephalitis and acute encephalitis syndrome hospitalizations in the medium-endemic region in Central India. J Epidemiol Glob Health. 2023. doi:10.1007/s44197-023-00110-7
5. Itihas A, Jategaonkar S, Jain M, Narang R, Chauhan V, Tandale BV, Tomar SJ. Comparison of clinical profile and outcomes of Japanese encephalitis and acute encephalitis syndrome among rural children. Indian J Pediatr. 2023. doi:10.1007/s12098-022-04424-5
6. Tandale BV, Khude PM, Deshmukh PS, Narang R, Qazi MS, Padmaja GV, Jain M, Jain D, Guduru VK, Deshmukh PR, et al; Japanese Encephalitis Epidemiology Study Group (Tomar SJ). Effectiveness of Japanese encephalitis vaccination among children in Central India. J Med Virol. 2023;95(1):e28399. doi:10.1002/jmv.28399
7. Tandale BV, Deshmukh PS, Narang R, Qazi MS, Padmaja GV, Deshmukh PR, Raut AV, Narlawar UW, Jha PK, Rajderkar SS; Japanese Encephalitis Epidemiology Study Group (Tomar SJ). Coverage of Japanese encephalitis routine vaccination among children in Central India. J Med Virol. 2022. doi:10.1002/jmv.28155
8. Tomar SJ, Alagarasu K, More A, Nadkarni M, Bachal R, Bote M, Patil J, Venkatesh V, Parashar D, Tandale BV. Decadal change in seroprevalence of chikungunya virus infection in Pune City, India. Viruses. 2022;14(5):998. doi:10.3390/v14050998
9. Alagarasu K, Potdar VA, Vipat V, Hundekar S, Gunjikar R, Choudhary ML, Abraham P, Lole KS; NIC Team (Tomar SJ). Utility of a modified heat inactivation method for direct detection of SARS-CoV-2 by RT-qPCR bypassing RNA extraction. Indian J Med Res. 2020;152(1-2):108-110. doi:10.4103/ijmr.IJMR_3121_20
10. Potdar V, Choudhary ML, Bhardwaj S, Ghuge R, Sugunan AP, Gurav Y, Yadav PD, Shete A, Tomar SJ, Anukumar B, et al. Respiratory virus detection among overseas returnees during the early phase of the COVID-19 pandemic in India. Indian J Med Res. 2020;151(5):486-489. doi:10.4103/ijmr.IJMR_638_20
11. Potdar V, Cherian SS, Deshpande GR, et al; NIC Team (Tomar SJ). Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran, and China, and Italian tourists in India. Indian J Med Res. 2020;151(2-3):255-260. doi:10.4103/ijmr.IJMR_1058_20
12. Alagarasu K, Choudhary ML, Lole KS, Abraham P, Potdar V; NIC Team (Tomar SJ). Evaluation of RdRp and ORF1b-nsp14-based real-time RT-PCR assays for confirmation of SARS-CoV-2 infection. Indian J Med Res. 2020;151(5):483-485. doi:10.4103/ijmr.IJMR_1256_20
13. Tandale BV, Tomar SJ, Bondre VP, Sapkal GN, Damle RG, Narang R, Qazi MS, Padmaja GV, Jain M, Jain D, et al; Infectious Encephalitis Aetiologies Study Group. Infectious causes of acute encephalitis syndrome hospitalizations in Central India, 2018–2020. J Clin Virol. 2022;152:105194. doi:10.1016/j.jcv.2022.105194
14. Tomar SJ, Thomson BG, Kanitkar SA, Bondre VP. HSV-2 meningitis in a young woman presenting with acute tonsillitis. Ann Indian Acad Neurol. 2023. doi:10.4103/aian.aian_425_22
15. Tomar SJ, Lodha R, Das B, Sood S, Kapil A. Risk factors for central line–associated bloodstream infections. Indian Pediatr. 2016;53(9):790-792. doi:10.1007/s13312-016-0932-y
16. Tomar SJ, Lodha R, Das B, Kapil A. Hand hygiene compliance of healthcare workers in a pediatric intensive care unit. Indian Pediatr. 2015;52(7):620-621.
17. Tomar SJ, Lodha R, Sreenivas V, Das B, Sood S, Kapil A. Incidence and risk factors for central line–associated bloodstream infections in a pediatric ICU. J Patient Saf Infect Control. 2015;3(2):106-107. doi:10.1016/j.jpsic.2015.10.173
18. Tomar SJ, Lodha R, Das B, Sood S, Kapil A. Central line–associated bloodstream infections: microbiology and antimicrobial resistance pattern in a pediatric ICU. Clin Epidemiol Glob Health. 2015;3(suppl):S16-S19. doi:10.1016/j.cegh.2015.10.008

Book Chapters: 05

1. Teja KB, Bhagavatula S, Bhatta A, Tomar SJ. Hepatitis C virus infection: current trends in host–pathogen interactions, diagnostics, and treatment. In: Bhukya PL, Subbaiyan A, eds. Emerging Human Viral Diseases. Vol II. Springer; 2024. doi:10.1007/978-981-97-4480-0_20
2. Bhatta A, Sahoo S, Teja KB, Tomar SJ. Middle East respiratory syndrome coronavirus (MERS-CoV). In: Bhukya PL, Mhaske ST, Sonkar SC, eds. Emerging Human Viral Diseases. Vol I. Springer; 2023. doi:10.1007/978-981-99-2820-0_6
3. Akshay PS, Veena SM, Teja KB, Tomar SJ. Severe acute respiratory syndrome–associated coronavirus (SARS-CoV). In: Bhukya PL, Mhaske ST, Sonkar SC, eds. Emerging Human Viral Diseases. Vol I. Springer; 2023. doi:10.1007/978-981-99-2820-0_5
4. Tomar SJ, Cherian S, Abraham P. Understanding the virus. In: COVID-19 Pandemic (History, Science & Society). Ministry of Information and Broadcasting, Government of India; 2021. ISBN:978-93-5409-175-9
5. Chowdhury PK, Shilpa Tomar, Mandal T. Changing epidemiology of dengue in Southeast Asia. In: Dengue. 2nd ed. New Delhi, India: Jaypee Brothers Medical Publishers; 2019:20–26. ISBN: 978-93-5270-672-3.